c-MYC (MYC) Protein Expression and Associations with Trastuzumab Benefit in Early-Stage, HER2+ Breast Cancer in Context of the NCCTG Adjuvant Trial, N9831
- Citation:
- Cancer Res vol 70 (24, suppl 2) abstr P2-09-08
- Meeting Instance:
- SABCS 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 1056
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- MM Reinholz AC Dueck AE Wiktor WL Lingle RB Jenkins NE Davidson S Martino PA Kaufman LA Kutteh GW Sledge LN Harris JR Gralow X Geiger EA. Perez
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: